Anticonvulsants (antineuropathics) for neuropathic pain syndromes

Clinical Journal of Pain

Volumn 16, Issue 2 SUPPL., 2000, Pages

  Backonja, Misha Miroslav ^a,b  

^a UNIVERSITY OF WISCONSIN MADISON   (United States)

^b University of Wisconsin Health   (United States)

Author keywords

Anticonvulsants; Hyperalgesia; Neuropathic pain; Pain modulation

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; AMITRIPTYLINE; ANTIARRHYTHMIC AGENT; ANTICONVULSIVE AGENT; ANTINOCICEPTIVE AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CLONAZEPAM; FLUPHENAZINE; GABAPENTIN; LAMOTRIGINE; LORAZEPAM; NEUROLEPTIC AGENT; NITRAZEPAM; NORTRIPTYLINE; PHENYTOIN; PIMOZIDE; PLACEBO; TIZANIDINE; TOCAINIDE; VALPROIC ACID;

ALLODYNIA; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIABETIC NEUROPATHY; DOUBLE BLIND PROCEDURE; DRUG INDICATION; DRUG INDUCED DISEASE; DRUG MECHANISM; HUMAN; HYPERALGESIA; NEUROPATHY; PAIN; POSTHERPETIC NEURALGIA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TRIGEMINUS NEURALGIA;

EID: 0034123531     PISSN: 07498047     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002508-200006001-00012     Document Type: Conference Paper

References (44)

1. Thomas RJ. Excitatory amino acids in health and disease. J Am Geriatr Soc 1995;43:1279-89.
2. Coderre TJ, Melzack R. The contribution of excitatory amino acids to central sensitization and persistent nociception after formalin-induced tissue injury. J Neurosci 1992;12:3665-70.
3. Sotah M, FW F. A mechanism of carbamazepine analgesia as shown by bradykinin-induced trigeminal pain. Brain Res Bull 1983;10:407-9.
4. McNamara J. Drugs acting on the central nervous system. In: Harman G, Limbird LE, Morinoff PB, EAL, eds. Goodman's and Gilman's the pharmacological basis of therapeutics. New York: McGraw-Hill;1996:461-86.
5. Tanelian DL, Cousins MJ. Combined neurogenic and nociceptive pain in a patient with Pancoast tumor managed by epidural hydromorphone and oral carbamazepine. Pain 1989;36:85-8.
6. Tanelian DL, MacIver MB. Analgesic concentrations of lidocaine suppress tonic A-delta and C fiber discharges produced by acute injury. Anesthesiology 1991;74:934-6.
7. Blom S. Trigeminal neuralgia: its treatment with a new anticonvulsant drug. Lancet 1962;1:839-40.
8. Blom S. Tic douloureux treated with new anticonvulsants. Arch Neurol 1963;9:285-90.
9. Campbell FG, Graham JG, Zilkha KJ. Clinical trial of carbamazepine (Tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry 1966;29:265-7.
10. Nicol C. A four year double blind randomized study of Tegretol in facial pain. Headache 1969;9:54-7.
11. Rockliff BW, Davis EH. Controlled sequential trials of carbamazepine in trigeminal neuralgia. Arch Neurol 1966;15:129-36.
12. Killian JM, Fromm GH. Carbamazepine in the treatment of neuralgia. Arch Neurol 1968;19:129-36.
13. Lechin F, van der Dijs B, Lechin ME, et al. Pimozide therapy for trigeminal neuralgia. Arch Neurol 1989;46:960-3.
14. Lindstrom P, Lindblom U. The analgesic effect of tocainide in trigeminal neuralgia. Pain 1987;28:45-50.
15. Vilming ST, Lyberg T, Lataste X. Tizanidine in the management of trigeminal neuralgia. Cephalalgia 1986;6:181-2.
16. Rull JA, Quibrera R, González-Millan H, et al. Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine: double-blind crossover study. Diabetologia 1969;5:215-20.
17. Wilton T. Tegretol in the treatment of diabetic neuropathy. S Afr Med J 1974;27:869-72.
18. Gomez-Perez FJ, Choza R, Ríos JM. et al. Nortriptyline-fluphenazine vs. carbamazepine in the symptomatic treatment of diabetic neuropathy. Arch Med Res 1996;27:525-9.
19. Facchetti D, Chiroli S, Bascelli C, et al. Gabapentin (GBP) versus carbamazepine in conservative treatment of carpal tunnel syndrome. Neurology 1999;52(Suppl 2):A203 (abstract).
20. Leijon G, Boivie J. Central post-stroke pain - a controlled trial of amitriptyline and carbamazepine. Pain 1989;36:27-36.
21. Bergouignan M. Cures heureuses de nevralgies faciales essentielles par diphenyl-hidantoinate de soude. Rev Laryngol Otol Rhinol (Bord) 1942;63:34-41.
22. Yaari Y, Devor M. Phenytoin suppresses spontaneous ectopic discharge in rat sciatic nerve neuromas. Neurosci Lett 1985;58:117-22.
23. Chadda VS, et al. Double blind study of the effects of dyphenyl-hidantoin sodium in diabetic neuropathy. J Assoc Physicians India 1978;26:403-6.
24. Saudek CD, Werns S, Reidenberg MM. Phenytoin in the treatment of diabetic symmetrical polyneuropathy. Clin Pharmacol Ther 1977;22:196-9.
25. Yajnik S, Singh GP, Singh G, Kumar M. Phenytoin as a coanalgesic in cancer pain. J Pain Symptom Manage 1992;7:209-13.
26. Webb J, Kamali F. Analgesic effects of lamotrigine and phenytoin on cold-induced pain: a crossover placebo-controlled study in healthy volunteers. Pain 1998;76:357-63.
27. McQuay H, Carroll D, Jadad A, et al. Anticonvulsant drugs for management of pain: a systematic review. BMJ 1995;311:1047-52.
28. McCleane GJ. Intravenous infusion of phenytoin relieves neuropathic pain: a randomized, double-blinded, placebo-controlled, crossover study. Anesth Analg 1999;89:985-8.
29. Sawynok J. GABA-ergic mechanisms of analgesia: an update. Pharmacol Biochem Behav 1987;26:463-74.
30. Max MB, Schafer SC, Culnane M, et al. Amitriptyline, but not lorazepam, relieves postherpetic neuralgia. Neurology 1988;38: 1427-32.
31. Peiris JB, Perera GLS, Dvendra SV, et al. Sodium valproate in trigeminal neuralgia. Med J Aust 1980;2:278-9.
32. Savitskaya O. Comparative effectiveness of anti-epileptic preparations in treatment of patients with neuralgia of the trigeminal nerve. Zh Nevrol Psikhiatr Im S S Korsakova 1980;80:530-5.
33. Drewes AM, Andreasen A, Poulsen LH. Valproate for treatment of chronic central pain after spinal cord injury: a double-blind crossover study. Paraplegia 1994;32:565-9.
34. Leach MJ, Marden CM, Miller AA. Pharmacological studies on lamotrigine, a novel potential antiepileptic drug. II. Neurochemical studies on the mechanism of action. Epilepsia 1986;27:490-7.
35. Zakrzewska JM, Chaudhry Z, Nurmikko TJ, et al. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain 1997;73:223-30.
36. Simpson DM, Olney R, McArthur J, et al. Lamotrigine in the treatment of HIV-associated painful sensory polyneuropathy: a placebo-controlled study. Neurology 1999;52(Suppl 2):A190 (abstract).
37. McCleane G. 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo-controlled trial. Pain 1999;83:105-7.
38. Taylor CP, Gee NS, Su T-Z, et al. A summary of mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res 1998;29: 233-19.
39. Field MJ, McCleary S, Hughes J, Singh L. Gabapentin and pregabalin, but not morphine and amitriptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999;80:391-8.
40. Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. JAMA 1998;280: 1831-6.
41. Rowbotham M, Harden N, Stacey B, et al. Gabapentin for the treatment of post-herpetic neuralgia: a randomized controlled trial. JAMA 1998;280:1837-42.
42. Vinik A, Fonseca V, Lamoeaux L, et al. Neurontin (gabapentin, GBP) improves quality of life (QOL) in patients with painful diabetic peripheral neuropathy. Diabetes 1998;46(Suppl 1):A374.
43. Morello CM, Leckband SG, Stoner CP, et al. Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain. Arch Intern Med 1999; 159:1931-7.
44. Gorson KC, Schott C, Rand WM, et al. Gabapentin in the treatment of painful diabetic neuropathy: a placebo-controlled, double-blind, crossover trial. Neurology 1998;50(Suppl 4):A103.